1. Home
  2. OGN vs CYD Comparison

OGN vs CYD Comparison

Compare OGN & CYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.31

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$46.20

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
CYD
Founded
1923
1951
Country
United States
Singapore
Employees
N/A
9189
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
OGN
CYD
Price
$13.31
$46.20
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$11.40
$60.00
AVG Volume (30 Days)
15.2M
94.2K
Earning Date
05-07-2026
02-24-2026
Dividend Yield
0.60%
1.32%
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
$6,216,000,000.00
N/A
Revenue This Year
$0.45
$15.11
Revenue Next Year
$1.67
$8.67
P/E Ratio
$24.26
$32.71
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$16.77
52 Week High
$13.44
$56.55

Technical Indicators

Market Signals
Indicator
OGN
CYD
Relative Strength Index (RSI) 77.58 64.41
Support Level $8.59 $35.24
Resistance Level N/A $56.55
Average True Range (ATR) 0.32 1.98
MACD 0.10 0.42
Stochastic Oscillator 97.87 96.75

Price Performance

Historical Comparison
OGN
CYD

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

Share on Social Networks: